News and Announcements
Cash Receipts from Customers Up 123% in Q1 for YPB Group
- Published May 02, 2016 3:09PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th APril 2016, ASX Announcement
Highlights
- Q1 cash receipts from customers increased 123% vs Q4 in 2015
- Affyrmx JV, established in Q1 2016, showing excellent early promise in the Government vital documents segment, receiving four orders since launch
- Currently servicing 152 active customer accounts across the world
- Strong business development pipeline in place with over 150 active projects
Overview
Global anti-counterfeit and brand protection solution company YPB Group Limited (ASX: YPB) is pleased to report a strong quarter-on-quarter increase in cash receipts of 123% to A$775,00 in Q1 2016. As part of its Appendix 4C for the period ending 31 March 2016, following is an update on corporate activities.
YPB has built an outstanding launchpad from which to strongly grow revenue and move the company into profitability in 2017.
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
